#APLAR22

Speakers

We are pleased to announce the below plenary and invited speakers for APLAR 2022. 

Browse through their profiles, by clicking on their photo for more information. 

New speakers are always being confirmed, so be sure to check back regularly for new additions!

Prof. Debashish Danda
India
Prof. Annamaria Iagnocco
The University Of Turin, Italy
Prof. Eric Morand
Monash University School Of Clinical Sciences, Australia
Prof. Kenneth Saag
University Of Alabama At Birmingham, United States
Prof. Dr. Georg Schett
Universitätsklinikum Erlangen, Department of Medicine 3, Germany
Prof. Tsutomu Takeuchi
Japan
Dr. Sakir Ahmed
Kalinga Institute Of Medical Sicences, India
Prof. Sulaiman Al-Mayouf
King Faisal Specialist Hospital & Research Center, Saudi Arabia
Dr. Elizabeth Ang
National University Hospital, Singapore
A/Prof. Thaschawee Arkachaisri
Kk Women's And Children's Hospital, Duke-nus Medical School, Singapore
Prof. Tatsuya Atsumi
Hokkaido University, Japan
Dr. Sunith Himantha Atukorale
Ministry Of Health, Sri Lanka
Dr. Elaine Au
Queen Mary Hospital, Hong Kong
A/Prof. Christine Bernal
University Of Santo Tomas, Philippines
Dr. Cynthia Chan
Pamela Youde Nethersole Eastern Hospital, Hong Kong
Prof. T M Chan
University of Hong Kong, Hong Kong
Dr. Shirley Chiu Wai Chan
University Of Hong Kong, Hong Kong
Assoc. Prof. Sumapa Chaiamnuay
Phramongkutklao Hospital, Thailand
Dr Ho Yin Chung
Hong Kong Society Of Rheumatology, Hong Kong
Prof. Francesco Ciccia
University Della Campania L. Vanvitelli, Italy
Dr. Thorlene Egerton
The University Of Melbourne, Australia
Dr. Ivan Foeldvari
Hamburger Zentrum Für Kinder- Und Jugendrheumatologie, Germany
Prof. Dirk Elewaut
Vib Center For Inflammation Research; Ghent University, Belgium
Prof. Sumaira Farman
National Hospital & Medical Center; Central Park Medical College; FJMU; Arthritis Care Foundation, Pakistan
Dr. Shunsuke Furuta
Chiba University Hospital, Japan
Dr Takahisa Gono
Department Of Allergy And Rheumatology, Nippon Medical School Graduate School Of Medicine, Japan
Latika Gupta
India
Prof. Rebecca Grainger
University of Otago, New Zealand
Dr. Laniyati Hamijoyo
University Of Padjadjaran, Indonesia
Prof. Masayoshi Harigai
Tokyo Women's Medical University, Japan
Dr. Tze Kwan, Carmen Ho
Queen Mary Hospital, Hong Kong
Dr. Matthew Jiang
Western Health, Australia
Prof. Alireza Khabbazi
Connective Tissue Diseases Research Center, Tabriz University Of Medical Sciences, Tabriz, Iran
Dinesh Khanna
University of Michigan, United States
Prof. Masataka Kuwana
Nippon Medical School, Japan
Prof. Mitsumasa Kishimoto
Kyorin university school of medicine, Japan
Ms Kwok Suet Kei
Hospital Authority, Hong Kong
A/Prof. Yohei Kirino
Yokohama City University, Japan
Dr. Laura Lewandowski
Head, Lupus Genomics and Global Disparities Unit, NIAMS, NIH, United States
Dr. Philip Li
The University of Hong Kong, Hong Kong
Prof. Worawit Louthrenoo
Thailand
Dr. Kuo-Lung Lai
Division Of Allergy, Immunology And Rheumatology, Department Of Internal Medicine, Taichung Veterans General Hospital, Taiwan
Prof. Chak-Sing Lau
The University of Hong Kong, Hong Kong
Dr. Vince Lau
Gleneagles Hospital, Hong Kong
Dr. Ka Wing Gavin Lee
Hong Kong Sanatorium & Hospital, Hong Kong
Dr. Victor Lee
CUHK Medical Centre, Hong Kong
Katy Leung
Singapore General Hospital, Singapore
Prof. Vidya Limaye
Royal Adelaide Hospital, Australia
Prof. Liwei Lu
The University of Hong Kong, Hong Kong
Prof. Ingrid Lundberg
Karolinska Institutet, Sweden
Assoc. Prof. Dr. PhD Peter Mandl
Division Of Rheumatology, Medical University Of Vienna, Austria
Prof Ashish Jacob Matthew
Christian Medical College, Vellore, India
Prof. Iain McInnes
United Kingdom
A/Prof. Takako Miyamae
Tokyo Women's Medical University, Japan
Prof. Ingrid Moller
Instituto Poal De Reumatologia Barcelona, University Of Barcelona International University Of Catalunya, Spain
Prof. Sandra Navarra
University Of Santo Tomas, Philippines
Prof. Fai Ng
Newcastle University, United Kingdom
Dr. Rachel Nelligan
The University Of Melbourne, Australia
Prof. Alexis Ogdie
University of Pennsylvania, United States
A/Prof. Kenji Oku
Department of Rheumatology and infectious Diseases, Kitasato University, Japan
Dr. Kade Paterson
Centre For Health, Exercise & Sports Medicine, He Unversity Of Melbourne, Australia
Dr. Jung Yoon Pyo
Yonsei University College Of Medicine, South Korea
Prof. Chaim Putterman
Bar Ilan Universtiy/Albert Einstein College Of Medicine, United States
Dr. Anthony Michael Sammel
Prince Of Wales Hospital, Australia
Prof. Chris Scott
University Of Cape Town, South Africa
Prof. Kichul Shin
Seoul Metropolitan Government-seoul National University Boramae Medical Center, South Korea
Prof. Lai-Shan Tam
The Chinese University Of Hong Kong, Hong Kong
Prof. Yoshiya Tanaka
University of Occupational and Environmental Health, Japan
Prof. Annette Van der van Mil
Leiden University Medical Center, Netherlands
Prof. Chrong-Reen Wang
National Cheng Kung University Hospital And Medical College, Taiwan
Dr. Priscilla Wong
The Chinese University of Hong Kong, Hong Kong
Prof. Tian Xinping
Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, China
Prof. Guochun Wang
China-japan Friendship Hospital, China
MD Julie Yu
Philippine Rheumatology Association, Philippines
Prof. Raymond Yung
University of Michigan, United States
Prof. Kazuhiko Yamamoto
Riken Center for Integrative Medical Sciences, Japan
Prof. Zhuo-Li Zhang
Peking University First Hospital, China
Prof. Vahid Ziaee
Tehran University of Medical Sciences, Iran
Prof. Ali Zubairi
Aga Khan University, Pakistan
Translate »

Prof. Debashish Danda

India

Prof. Annamaria Iagnocco

The University Of Turin, Italy

Annamaria Iagnocco is Professor of Rheumatology and Head of the Academic Rheumatology Centre at Turin University, Italy. She is EULAR President. She is former Head of the EULAR School of Rheumatology, former co-chair of the OMERACT Ultrasound Group, Chair of the Ultrasound Study Group of the Italian Society for Rheumatology, member of several working groups on ultrasound in RMDs and faculty teacher in the EULAR Sonography Courses. Her research interests in RMDs include education, arthritis, and imaging. She is a member of the Editorial Board of prestigious international journals and has authored more than 290 peer-reviewed publications.

Prof. Eric Morand

Monash University School Of Clinical Sciences, Australia

Professor Morand graduated from Monash University, trained in rheumatology in Australia and the Royal National Hospital for Rheumatic Diseases, UK. His laboratory focusses on glucocorticoid-induced proteins in the immune system, and his clinical research on systemic lupus erythematosus. He founded the Asia Pacific Lupus Collaboration, which has focused on developing and validating new endpoints for SLE, including the Lupus Low Disease Activity State (LLDAS), now widely incorporated in clinical trials. He lead the TULIP2 trial of anifrolumab in SLE, resulting in regulatory approval of anifrolumab in the US, Japan, and EU.
Awards include the William E Paul Distinguished Innovator Award of the Lupus Research Alliance, New York, and the Parr Prize of the Australian Rheumatology Association.

Prof. Kenneth Saag

University Of Alabama At Birmingham, United States

Dr. Saag is Professor of Medicine and holds the Jane Knight Lowe Endowed Chair in the Department of Medicine at the University of Alabama at Birmingham. At UAB he is also Director of the Division of Clinical Immunology and Rheumatology, Director of the Comprehensive Arthritis, Musculoskeletal, Bone, and Autoimmunity Center, and Director of the Center of Research Translation in Gout and Hyperuricemia.

Proud to have grown up in the diverse city of Evanston, Illinois, where he became an Eagle Scout and graduated third in his high school class of over 1,000 students, Dr. Saag was trained as a bioengineer at the University of Michigan, and received his MD from Northwestern University. As a medical resident at Evanston Hospital, he was recognized as Outstanding Intern of the Year and as a Chief Resident. While at the University of Iowa completing his fellowship in rheumatology, he simultaneously earned an MSc in epidemiology. At Iowa, he began his interest in and pursuit of clinical epidemiology and experimental therapeutics. Dr. Saag continued at the University of Iowa as an Assistant Professor until joining the University of Alabama at Birmingham, where he has been a practicing physician, educator, and research scientist since 1998.
Dr. Saag’s research has advanced the field of implementation science and disparities research in the areas of osteoporosis and gout. His recent work has focused on methods to implement evidence into practice using novel study designs. Using cohorts and other large databases, he has contributed to an understanding of comparative effectiveness and safety of drugs in rheumatoid arthritis, osteoporosis, and gout. He has authored more than 400 peer-reviewed manuscripts, including 3 original first-author articles in the New England Journal of Medicine on treatment of glucocorticoid-induced osteoporosis and on fracture prevention in women with osteoporosis. He has also authored more than 100 reviews, editorials, and book chapters, as well as the fi rst and second editions of the clinical handbook Diagnosis and Management of Osteoporosis. He has served on the editorial boards of Arthritis Care & Research, Annals of Internal Medicine, Archives of Internal Medicine, Bone, and other biomedical journals. As a research mentor, he has trained more than 20 postdoctoral fellows and junior faculty and has been principal investigator on several large program project grants at UAB. He directs the K and T training components for the UAB Center for Clinical and Translational Science. He served a term as a standing member on the NIH Neurologic Aging and Musculoskeletal Epidemiology (NAMES) study section and chaired the Arthritis Foundation Review Commit-tee, Clinical Outcomes and Therapeutics Study Section in the past.

Dr. Saag has been frequently recognized for his contributions to research and research training. Among the honors he has received are the UAB Max Cooper Research Award in 2005, the UAB Department of Medicine Research Award (fi rst place among professors) in 2012–2014, the 2017 UAB Dean’s Excellence Award for Mentor-ship, and the 2021 European Calcified Tissue Society Excellence in Research Award. He was elected to the Association of American Physicians in 2015. In 2013 the ACR honored him with its Excellence in Investigative Mentoring Award. He has been listed in Best Doctors annually since 1996. Through his research pursuits he has been a very frequent lecturer in all continents except Antarctica and has particularly enjoyed his collaborations and visiting professorships in Latin America. Past lectureships and plenary presentations have included visits to EULAR, PANLAR, APLAR, the European Calcified Tissue Society, the International Osteoporosis Foundation, the Australian and New Zealand Bone and Mineral Society, as well as rheumatology and metabolic bone disease societies in 30 countries.
Throughout his career, Dr. Saag has served actively in numerous medical professional and patient advocacy organizations, and has been particularly focused on developing practice guidelines and quality of care indicators. In 1998–2002 he was a member of the Institute of Medicine Committee on Identifying Effective Treatment for Gulf War Veterans’ Health Problems. In the early 2000s he served on the American Medical Association Osteoarthritis Performance Measures Physicians Workgroup, the National Center for Quality Assurance Musculoskeletal Workgroup, and the American Pain Society Low Back Pain Guidelines Committee. He was a member of the Ameri-can Society for Bone and Mineral Research Advocacy Committee in 2010–2013 and Program Co-Chair of the organization’s 2017 Meet-ing Planning Committee. He served on the National Osteoporosis Foundation Board of Trustees in 2008–2013 and was Vice-President of the organization in 2014–2016 and President in 2016–2018, during which time he also served as Co-Chair of the National Bone Health Alliance. He was a member of the American Gout Society Board of Directors in 2005–2020. In addition, he has served on the FDA Arthritis Drugs Advisory Committee and on numerous panels and work-ing groups of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, including delivering the keynote address on career journey for the NIAMS K-Trainees Forum in 2019.

A member of the American College of Rheumatology since 1992, Dr. Saag’s active involvement with the ACR began early in his career. He served on the Atypical Connective Tissue Diseases Classification Criteria Subcommittee and the Ad Hoc Committee to Revise Guidelines for Glucocorticoid-Induced Osteoporosis in 1998 and on the Professional Meetings Committee in 1998–2001. He was the senior author on 2 prior iterations of the ACR rheumatoid arthritis guidelines and he served as the American delegate to past EULAR rheumatoid arthritis guidelines. He also served as the senior author on the ACR COVID-19 treatment guidance document produced in 2020. He chaired the Summer Rheumatology Meeting Planning Committee in 2001 and was a member of the Educational Products Committee and the Academic Rheumatology Workforce Ad Hoc Committee in 2002. He served as Co-Chair of the ACR Quality Measures Subcommittee in 2007–2009, as Chair of the Committee on Quality of Care in 2009–2013, and as Chair of the Committee on Corporate Relations from 2018 to 2020. During his time on these committees he helped fashion new approaches to guideline development and advised the College on public–private partnerships during the start of the pandemic. Dr. Saag was appointed to the ACR Board of Directors in 2013 and to the ACR Finance Committee in 2016. He served as ACR Secretary in 2018–2020 and as President-Elect in 2020–2021.
Dr. Saag resides in Birmingham with his wife Leah. They have 3 daughters, Jenny (Christopher) Keshishian, Lauren (Yitzi) Peet-luk, and Stefanie Saag, who work as a certified nurse anesthetist at UAB, an epidemiologist faculty member at Vanderbilt University, and a social work student in Chicago, respectively. Dr. Saag and his wife enjoy international travel, hiking, eclectic food and wine, and in particular, spending time with their children, granddaughter Clara Keshishian, parents Jim Saag and Marlene Waller, extended family/friends throughout the country, and a large cadre of family dogs.

Prof. Dr. Georg Schett

Universitätsklinikum Erlangen, Department of Medicine 3, Germany

Georg Schett is professor of Internal Medicine and since 2006 head of the Department of Medicine 3 – Rheumatology and Immunology at Universitätsklinikum Erlangen, Friedrich-Alexander University Erlangen-Nürnberg in Germany.

Professor Schett graduated from the University of Innsbruck (Austria) in 1994. After his dissertation from medical school, he worked as scientist at the Institute of BioMedical Aging Research of the Austrian Academy of Science in Innsbruck. Two years later, he joined the Department of Medicine at the University of Vienna, where he completed his postgraduate training in Internal Medicine and subsequently in Rheumatology. In 2003 he was promoted to professor of Internal Medicine. Before accepting his position as the chair of the Department of Internal Medicine 3 in Erlangen, he worked as a scientist in the United States of America for one year.

Georg Schett’s scientific work includes a broad spectrum of clinical and immunological issues, particularly the molecular basics of immune-inflammatory diseases. Initially, he investigated the immunology of atherosclerosis and focused on antibody-mediated endothelial cell damage. His research work led to the understanding of the phenomenon of LE-cells in 2007. He was awarded the renowned START Award in 2002 and established a research group for arthritis in Vienna. In 2008, he initiated in collaboration with colleagues the priority program IMMUNOBONE in Germany, funded by the German Research Foundation (DFG). IMMUNOBONE aims to elucidate the interactions between the skeletal and the immune systems. Since 2015, Prof. Schett has led the DFG collaborative research centre 1181 “Checkpoints for Resolution of Inflammation” in Erlangen. Additionally, he is spokesperson of the project METARTHROS, funded by the Federal Ministry of Education and Research, which investigates the impact of the metabolism on arthritis. In 2019, he received funding for the ERC-Synergy grant “4D+ nanoSCOPE Advancing osteoporosis medicine by observing bone microstructure and remodelling using a four-dimensional nanoscope” of which he is spokesperson. 4D nanoSCOPE aims to develop tools and techniques to permit time-resolved imaging and characterization of bone in three spatial dimensions (both in vitro and in vivo), thereby permitting monitoring of bone remodelling and revolutionizing the understanding of bone morphology and its function.

In 2021, Prof. Schett was appointed Vice President Research of Friedrich-Alexander University Erlangen-Nürnberg and also became a Leopoldina member of the National Academy of Sciences of Germany.

Professor Schett’s scientific work has been honored with several awards, including the Carol-Nachman Prize from Wiesbaden. He has published over 840 peer-reviewed papers.

Prof. Tsutomu Takeuchi

Japan
Present

Division of Rheumatology,
Department of Internal Medicine,
Keio University School of Medicine
Professor of Internal Medicine,
Chief of Rheumatology,
Vice dean, Keio University School of Medicine (October 1, 2011~Semptember 30, 2013)
General Director of Keio University Hospital (October 1, 2013~July 31, 2017)
Vice President of Keio University (August 1, 2017~present)

Dr Sakir Ahmed

Kalinga Institute Of Medical Sicences, India

Associate Professor; Clinician scientist and Editor; Interests include Digital Health, Fibrosis in rheumatic diseases and Pain pathways in rheumatic diseases.

Member of APLAR SIG on Digital Health and Telemedicine.
2019 APLAR Research Grant recipient

Prof. Sulaiman Al-Mayouf

King Faisal Specialist Hospital & Research Center, Saudi Arabia

Consultant of Pediatric Rheumatology at King Faisal Specialist Hospital & Research Center (KFSH-RC), Riyadh and Professor at Medical College, Alfaisal University.

Dr. Al-Mayouf served as a board- member of Saudi Society for Rheumatology.

He is the founder and member of Pediatric Rheumatology Arab Group (PRAG). He is the national coordinator for the Pediatric Rheumatology International Organization (PRINTO) and AutoInflammatory Disease Alliance (AIDA) Network.

Dr. Al-Mayouf authored numerous papers and reviews on pediatric rheumatology. In addition, he serves as a reviewer for several scientific journals. He is a frequent lecturing nationally and internationally in Pediatric Rheumatology.

Dr Elizabeth Ang

National University Hospital, Singapore

Elizabeth Ang is Senior Consultant, Paediatric Rheumatology in the Khoo Teck Puat-National University Children’s Medical Centre, National University Hospital, Singapore and Assistant Professor of the National University of Singapore Yong Loo Lin School of Medicine. She did her clinical Paediatric Rheumatology Fellowship in Boston Children’s Hospital/Harvard School of Medicine.

In her free time, she enjoys going to various countries in South East Asia to spread her love for Paediatric Rheumatology and to try and understand (and sometimes tackle, alongside local providers) the challenges of caring for children with rheumatic diseases there. She counts it her privilege to have made many friends and learnt much in the process. The COVID pandemic has restricted much of such travel in the last few years, which makes this upcoming congress especially precious to her.

A/Prof Thaschawee Arkachaisri

Kk Women’s And Children’s Hospital, Duke-nus Medical School, Singapore

Dr. Tash graduated from Mahidol University, Thailand in 1991. He then pursued his specialty and subspecialty training in the US and earned his American Board of Pediatrics, Allergy and Immunology and lastly, Pediatric Rheumatology at Cornell University prior to returning back to Thailand and established the first Pediatric Rheumatology department at Siriraj Hospital and Mahidol University in January 2001. He then moved back to the US and joined Children’s Hospital of Pittsburgh where he gained his research interest in scleroderma and established the first Pediatric Scleroderma clinical and research Program in 2006. Then, he developed the Localized Scleroderma Cutaneous Assessment Tool which is the well-accepted clinical assessment measures in Localized Scleroderma and has been well-accepted as the standard assessment worldwide. In 2009, he then moved back to Singapore to established its first Pediatric rheumatology clinical program and in 2011, the Asia-Pacific Pediatric Rheumatology Education and Research Network. Over the decades, he has published the epidemiologic and outcomes of children with rheumatic diseases in Singapore and Southeast Asia. He also actively involved in pediatric rheumatic diseases translational research in trying to better understand the underlying immune-mechanisms and predict outcomes. He is currently an Associate Professor, head and senior consultant at the Rheumatology and Immunology Department at KK Women’s and Children’s Hospital and Duke-NUS Medical School.

Prof. Tatsuya Atsumi

Hokkaido University, Japan

Tatsuya Atsumi, MD, PhD, Professor of Medicine in the Faculty of Medicine, Hokkaido University in Japan, is the head of the department of Rheumatology, Endocrinology and Nephrology.

After graduating at Hokkaido University in 1988, he has spent most of his carrier as a researcher in Sapporo, except 3 years in the Lupus Unit, St. Thomas’ hospital in London (1994-1997). His research interest includes clinical and basic aspect of systemic autoimmune diseases such as antiphospholipid syndrome, systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. He has over 600 research publications dealing with several aspects including rheumatology, in particular, with the pathogenesis, diagnosis and treatment of antiphospholipid syndrome.

Dr. Sunith Himantha Atukorale

Ministry Of Health, Sri Lanka

Dr Himantha Atukorale is a Consultant in Rheumatology & Rehabilitation working in the Ministry of Health, Sri Lanka. He is an International Fellow of American College of Rheumatology and Fellow of Royal College of Physicians of Edinburgh. Dr Himantha is also the webmaster and board member of APLAR Young Rheumatologists. He has been a founder interim board member of APLAR Young Rheumatologists. He is a visiting lecturer in Medical Faculty of Rajarata and also functions as a medical journalist. Dr Himantha had his training at several premier medical institutions in Sri Lanka and Rheumatology Unit at Dudley NHS Trust United Kingdom.

Dr. Elaine Au

Queen Mary Hospital, Hong Kong

Dr Elaine Au received her medical degree from the University of Hong Kong, and obtained her Physician fellowship in 2011, subspecialize in Rheumatology. In 2017, she completed her fellowship in Immunology under Pathology.

Dr Au currently is the consultant and Division Head of Clinical Immunology, Department of Pathology, in Queen Mary Hospital. She is also the chairman of the Immunology specialty board in the Hong Kong College of Pathologist. Dr Au is dedicated in immunology & allergy service development, both in clinical and laboratory service. She also actively participates in training and education. She is appointed as Honorary Clinical Associate Professor by both the Department of Medicine and the Department of Pathology of the University of Hong Kong.

A/Prof. Christine Bernal

University Of Santo Tomas, Philippines

Dr. Bernal is a pediatric rheumatologist who, after her residency training in pediatrics in UST Hospital, pursued her fellowship training in rheumatology in Baylor College of Medicine, Houston, Texas. While training abroad, she was a recipient of several prestigious awards including Drs. Ralph and Judith Feigin Resident Award of Excellence, American College of Rheumatology (ACR) outstanding fellow award and ACR Amgen Pediatric Rheumatology Research Award. Her research works on lupus, Kawasaki, polyarteritis nodosa and juvenile idiopathic arthritis has been published in international journals including Arthritis and Rheumatism, International Journal of Rheumatic Diseases and APLAR Journal of Rheumatology. She also authored chapters on lupus nephritis on Avner Pediatric Nephrology in 2021, on Disorders of Bones & Connective Tissues for Fundamentals of Pediatrics in 2014.and Juvenile idiopathic arthritis for Arthritis and Allied Conditions in 2005.

A graduate of UST Faculty of Medicine and Surgery, she now serves her alma mater as Associate Professor. At present, she is the section chief of Pediatric Rheumatology in UST Hospital and Cardinal Santos Medical Center; an active medical consultant in private tertiary hospitals in Metro Manila.

Dr Cynthia Chan

Pamela Youde Nethersole Eastern Hospital, Hong Kong

Dr Chan obtained her Doctor of Medicine degree from the University of British Columbia in 2001. She was a member of the College of Family Physicians of Canada before pursuing further training in psychiatry in Hong Kong in 2006. She became a Fellow of the Hong Kong College of Psychiatrists in 2013. She has published original articles in international journals in the area of mental health and spondyloarthritis.

Prof. T M Chan

University of Hong Kong, Hong Kong

Daniel Tak Mao Chan obtained his MBBS, MD, and DSc degrees from the University of Hong Kong (HKU). He became Professor at the HKU Department of Medicine in 1999, then Chair Professor in 2005, Yu Chair of Nephrology in 2008, and Yu Chiu Kwong Chair of Medicine in 2011. He has been Chief of Nephrology of HKWC Hospitals since 2010.

His research themes include lupus nephritis and viral hepatitis in patients with kidney diseases. His seminal works established mycophenolate as standard-of-care for the treatment of lupus nephritis globally, and strategies to prevent HBV and HCV complications in patients with kidney disease, both resulting in significantly improved patient outcomes. Translational studies from his laboratory have increased the understanding of pathogenic mechanisms in renal inflammation and fibrosis. His publications have appeared in New England Journal of Medicine, Kidney International, Journal of American Society of Nephrology, Arthritis Rheumatology, Nature Review Nephrology, Gastroenterology, and Hepatology. He is Lead Author for the Lupus Nephritis chapter in the 2021 KDIGO Clinical Management Guideline for Glomerulonephritis, and author of chapters on hepatitis B management in kidney disease patients in UpToDate.

He has served as Associate Dean, Senate member, and University Selection & Promotion Committee member at HKU, and is currently Member of the HKU Council. He also served as President of Asian Pacific Society of Nephrology (APSN), President of Hong Kong Society of Transplantation, Executive Committee member of Asian Society of Transplantation, HK West Cluster Hospitals Department of Medicine Chief of Clinical Service, Chairman of Hong Kong Hospital Authority Coordinating Committee in Internal Medicine, and Council member of International Society of Nephrology (ISN). Since 2016 he is Vice-President and Chairman of Education & Accreditation Committee of Hong Kong College of Physicians. He is serving on the Biology & Medicine panel of Hong Kong Research Grants Council Joint Research Scheme, and as grant reviewer for research funding institutes locally and overseas. He established the first (and only) ABO-incompatible kidney transplant program in Hong Kong at Queen Mary Hospital in 2017. He received the HKU Outstanding Researcher Award in 2006, and the APSN Kenzo Oshima Award in 2014.

Dr Shirley Chiu Wai Chan

University Of Hong Kong, Hong Kong

Dr Shirley Chan is a specialist in Rheumatology with special interests in spondyloarthritis and other autoimmune rheuamtic diseases. Dr Chan obtained her Bachelor of Medicine, Bachelor of Surgery (MBBS) degree from the University of Hong Kong (HKU). She then received her specialty training in Queen Mary Hospital. She is currenlty working as a Clinical Assistant Professor in HKU. One of her research interests covers the role of imaging in spondyloarthritis, including novel MRI sequence and the potential application of artificial intelligence in image interpretation.

Assoc. Prof. Sumapa Chaiamnuay

Phramongkutklao Hospital, Thailand

Associate Professor Sumapa Chaiamnuay graduated from the faculty of Medicine, Chulalongkorn University, Thailand. She completed Internal Medicine residency training from Albert Einstein Medical Center, Philadelphia, and Rheumatology fellowship training from The University of Alabama at Birmingham. She served as the past secretary of the Thai Osteoporosis Foundation. Currently, she is the Chief of Thai Osteoporosis Foundation Public Relations, and the chief of the Rheumatic Disease unit at Phramongkutklao hospital. Her research interest is osteoporosis in rheumatic disease patients, and she’s on the working committee for the Thai Osteoporosis Clinical Practice Guideline 2021.

Dr Ho Yin Chung

Hong Kong Society Of Rheumatology, Hong Kong

Chung Ho Yin is a medical consultant in Chiron Medical. He received his doctor of medicine and specialist training in Hong Kong and was a clinical assistant professor at the University of Hong Kong and an Associate Consultant at Queen Mary Hospital. He is a council member of the Hong Kong Society of Rheumatology, fellow of the Royal College of Physician (Edinburgh), and member of the special interest group (SIG) in spondyloarthritis of the Hong Kong Society of Rheumatology (HKSR) and Asia Pacific League of Associations for Rheumatology (APLAR). He is also the associate editor of the Journal of Clinical Rheumatology and Immunology and International Journal of Rheumatic Diseases. His areas of interest include application of magnetic resonance imaging (MRI) in axial spondyloarthritis. His research articles have been published in numerous international journals including an Editor’s Choice in the Annals of the Rheumatic Diseases. He was awarded outstanding free paper bronze prize in the 9th Guangdong-Hong Kong Rheumatology Seminar 2014, best free paper award, International Conference of Chinese Rheumatologists 2018, and best abstract in APLAR 2018 and 2021.

Prof. Francesco Ciccia

University Della Campania L. Vanvitelli, Italy

Prof. Francesco Ciccia is a MD and PhD, specialized in Internal Medicine and Rheumatology for many years involved in research on the immunological basis of sytemic autoimmune diseases. His training took place between the University of Palermo and the King’s College of London. Currently Dr. Ciccia holds the position of Full Professor of Rheumatology and head of the section of Clinical and Experimental Rheumatology at the University of Naples. The research of Professor. Ciccia is focused on the study of the innate and adaptive immune mechanisms involved in the pathogenesis of Ankylosing Spondylitis, psoriatic arthritis, Sjogren’s syndrome and giant cell vasculitis.

Dr Thorlene Egerton

The University Of Melbourne, Australia

Dr Thorlene Egerton is a senior lecturer with the Physiotherapy Department, and a senior research fellow with the Centre for Health, Exercise & Sports Medicine. Her current research interests are in bridging the evidence-practice gap in osteoarthritis management. She is particularly interested in novel models of care and education strategies to support effective self-management and behaviour change.

Thorlene coordinates the post-graduate masters of Clinical Rehabilitation. She teaches Health Behaviour Change, Evaluation of Rehabilitation Practice and Physical Activity & Exercise subjects as well as supervising the master students’ Research Project subject.

She has published 53 articles in peer-reviewed journals and produced a short patient education video explaining knee osteoarthritis with a novel empowerment discourse

Dr. Ivan Foeldvari

Hamburger Zentrum Für Kinder- Und Jugendrheumatologie, Germany
Academic Training

1979 Medical School J.W. Goethe University Frankfurt/M, Germany.
1980 Medical School Semmelweiss University Budapest, Hungary
1986 MD with “”summa cum laude”” Semmelweiss University, Budapest, Hungary
1995 End of a 2 year Paediatric Rheumatology Fellowship, with Prof. Dr. R.E. Petty, Children’s Hospital, University of British Columbia, Vancouver, Canada
1996 End of the Paediatric Residency (Germany)
1996 Head of the Paediatric Rheumatology Unit at the University Children´s Hospital in Hamburg
2000- Head of the Hamburger Zentrum für Kinder- und Jugendrheumatologie, at the Klinikum Eilbek, Hamburg
2007- Head of the Kompetenz – Zentrum für Sklerodermie und Uveitis im Kindes- und Jugendalter, at the Klinikum Eilbek, Hamburg
2011 Faculty at the Asklepius Campus Hamburg of the Semmelweiss Medical University, Budapest, Hungary”

Prof Dirk Elewaut

Vib Center For Inflammation Research; Ghent University, Belgium

Dirk Elewaut is a Full Professor of Rheumatology and Immunology and Chair of the Department of Rheumatology and Immunology at Ghent University Hospital, Ghent, Belgium, a European Alliance of Associations for Rheumatology (EULAR) and Federation of Clinical Immunology Societies (FOCIS) centre of excellence. He received his medical degree at Ghent University in 1991 and his PhD in 1997 at the same institution. Following his postdoctoral research at the University of California San Diego and the La Jolla Institute for Allergy and Immunology, CA, USA, he joined the faculty of the Department of Rheumatology at Ghent University Hospital in 2001.

He has published more than 300 scientific publications in leading scientific journals and is Principal Investigator of the Unit of Molecular Immunology and Inflammation of the VIB Center for Inflammation Research at Ghent University. Currently, he serves as Chair of the EULAR Research Center and as a member of the editorial boards of several leading rheumatology journals. He has received several awards including the 2020 Carol Nachman Award. His research interests are centred around translational aspects of immune regulation to combat inflammatory arthritis and associated joint damage, with a special focus on the link between gut and joint disease in spondyloarthritis

Prof. Sumaira Farman

National Hospital & Medical Center; Central Park Medical College; FJMU; Arthritis Care Foundation, Pakistan
Qualifications:

MRCP (UK); Specialty Certificate Examination (SCE) Rheumatology (UK); International Fellow of American College of Physicians (FACP) & Rheumatology (FACR); Fellow Royal College of Physicians (FRCP) London; GradCertPRheum (Australia).

Primarily an adult rheumatologist, she interned in pediatric rheumatology, Kansas University Medical Centre, USA through an ACP International Fellowship; and acquired the Graduate Certificate in Paediatric Rheumatology (GradCertPRheum) from the University of Western Australia.

Based in Lahore, Pakistan, she is Professor and Head of Rheumatology Department National Hospital & Medical Centre, Visiting Faculty and Chair of the Paediatric Rheumatology program at Central Park Medical College.
She is Associate Editor IJRD.
She is Focal Representative Global Paediatric MSK Task Force, and Convener APLAR Paediatric Rheumatology SIG.

She is Immediate Past President, Pakistan Society for Rheumatology Co-Founder & Co-Chairperson Arthritis Care Foundation, Lahore.

Dr Shunsuke Furuta

Chiba University Hospital, Japan
Education:
2008 Ph.D. (Dr. of Medical Science), Chiba University 2000 M.D. Chiba University School of Medicine
Professional Training and Employment:
2015-presentAssociate Professor in Department of Allergy and Clinical Immunology, Chiba University Hospital 2013-2015 Department of Allergy and Clinical Immunology, Chiba University Hospital 2012-2013 Research Fellow in Lupus and Vasculitis Clinic, Cambridge University Hospital, Cambridge, UK 2008-2011 Department of Allergy and Clinical Immunology, Asahi General Hospital 2004-2008Department of Allergy and Clinical Immunology, Chiba University Hospital 2003-2004 Internal Medicine, Yokohama Rousai Hospital 2001-2003Internal Medicine, Numazu City Hospital 2000-2001Resident in Internal Medicine, Chiba University Hospital
Certification:
2010 Japan College of Rheumatology-board Certified Rheumatologist

Dr. Takahisa Gono

Department Of Allergy And Rheumatology, Nippon Medical School Graduate School Of Medicine, Japan
Education & Training

UNDERGRADUATE/GRADUATE:
2004, Ph.D, Shinshu University Graduate School
1992-1998, Yamanashi University, Yamanashi, Japan, M.D. 1998

POSTGRADUATE:
2003-2004, Nagano National Hospital, Nagano, Japan, Medical Doctor in Internal Medicine (Rheumatology)
2000-2001, Iida Municipal Hospital, Nagano, Japan, Medical Doctor in Internal Medicine (Neurology)
1999-2000, Fujimi Kogen Hospital, Nagano, Japan, Resident in Internal Medicine
1998-1999, Shinshu University, Nagano, Japan, Resident in Internal Medicine

SPECIALITY CERTIFICATION
2002 The Japanese Society of Internal Medicine
2006 The Japanese Society of Neurology
2006 The Japanese College of Rheumatology

AWARD
2012 Young Investigator’s Award of the Japanese Society of Rheumatology
2013 Young Investigator’s Award of the Japanese Society of Internal Medicine

Appointments & Positions

ACADEMIC:
2016-Present: Associate Professor, Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine
2015-2016: Associate Professor, Department of Rheumatology, Saitama Medical Center, Jichi Medical University
2014-2015: Associate Professor, Institute of Rheumatology, Tokyo Women’s Medical University
2007-2014: Assistant Professor, Institute of Rheumatology, Tokyo Women’s Medical University
2004-2007: Assistant Professor, Third department of Internal Medicine (Rheumatology and Neurology), Shinshu University
2001-2003: Research fellow, Third department of Internal Medicine (Rheumatology and Neurology), Shinshu University

SCIENTIFIC SOCIETY:
Councilor of The Japanese College of Rheumatology
Councilor of The Japanese Society of Clinical Immunology
Editorial Board, BioMed Research International Journal

Latika Gupta

India

Dr Gupta is a rheumatologist, clinical immunologist, and clinician scientist working as Assistant Professor at SGPGI, a tertiary care teaching hospital in Lucknow, India. She currently serves as the Social Media Editor for several Rheumatology journals and is the APLAR (Asia Pacific League of Associations for Rheumatology) Young Rheumatology Webmaster and Board Member from India.

She is a dedicated researcher (136 publications, H index 12, I index 19) with an interest in myositis, spondyloarthritis and digital health. She recently founded Myositis India, a patient support group for patients with this disease.

Besides enjoying medical teaching Dr Gupta enjoys amateur photography, poetry, and photo painting.

Prof Rebecca Grainger

University of Otago, New Zealand

Rebecca is an academic rheumatologist who is passionate about patient-focused care and engaging with colleagues in primary and secondary care to provide the highest quality collaborative care for people with arthritis. A University of Otago medical graduate, she undertook rheumatology training in Melbourne and her PhD examined inflammatory mechanisms in gout. Rebecca’s clinical work focuses on the assessment and management of inflammatory arthritis and her particular clinical interests include inflammatory arthritis, gout and scleroderma. Rebecca’s academic interests include outcome measures, non-pharmacological management of musculoskeletal disease, use of information technology solutions to optimise care for people with chronic rheumatic diseases and medical education.

Dr. Laniyati Hamijoyo

University Of Padjadjaran, Indonesia

Laniyati Hamijoyo is a Rheumatology consultant at Internal medicine Department, Faculty of Medicine University of Padjadjaran Bandung, Indonesia. Currently she actively serves as member of several medical organisations, such as co-opted members of APLAR (2021-present), member of Asia Pacific Lupus Collaboration (APLC) (2013-present), and Lupus SIG of APLAR (2017-present), and Indonesian Rheumatology Association (IRA) (2010-present). She actively involves in several national or international clinical trials and has done several studies, been author, co-author, reviewer of several journals and books. Her main interest is in the field of Lupus, Spondyloarthritis and Gout.

Prof. Masayoshi Harigai

Tokyo Women’s Medical University, Japan

Masayoshi Harigai, MD, PhD is Professor and Head of Division of Rheumatology, Department of Internal Medicine, Tokyo Women’s Medical University, Tokyo, Japan. He served as Professor of Department of Pharmacovigilance at Tokyo Medical and Dental University between 2007 and 2015 and has been installed in the present position in 2019. Professor Harigai is the principal investigator of Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis, clinical trial of tocilizumab for ANCA-associated vasculitis, and 2020 Japanese Clinical Practice Guidelines for the Management of Rheumatoid Arthritis. He has been serving as a board member of Japan College of Rheumatology since 2018.

Dr. Tze Kwan, Carmen Ho

Queen Mary Hospital, Hong Kong

Dr Carmen Tze-Kwan HO
MBBS, FHKCP (HK), FHKAM (Med), FRCP (Edinburg, London)
Consultant of Queen Mary Hospital/ Tung Wah Hospital/ Grantham Hospital
Honorary Clinical Associate Professor, LKS Faculty of Medicine, The University of Hong Kong

Carmen graduated from The University of Hong Kong in 1992, subsequently became Consultant Rheumatologist of Queen Mary Hospital, Tung Wah Hospital and Grantham Hospital. She was the past President of The Hong Kong Society of Rheumatology from 2014-2018.

Dr Matthew Jiang

Western Health, Australia

Matthew Jiang is a rheumatologist based in Melbourne, Australia who works in public and private practice, including the Osteoarthritis Hip and Knee Service at St Vincent’s Hospital.

Prof Alireza Khabbazi

Connective Tissue Diseases Research Center, Tabriz University Of Medical Sciences, Tabriz, Iran

I was born in 1966 in Tabriz. I completed my high school education at Ferdowsi High School in Tabriz. I started studying medicine at Tabriz University of Medical Sciences in 1985. I studied specialty in internal medicine at Tabriz University of Medical Sciences from 1997 to 2001 and Subspecialty in rheumatology at Tehran University of Medical Sciences from 2003 to 2005. In 2005, I employed as an Assistant Professor in Internal Medicine group at medical faculty of Tabriz University of Medical Sciences. I became a professor in 2017. My positions are Research deputy in Internal Medicine group, manager of Vasculitis Registry of Connective Tissue Disease Research Center and Head of the Connective Tissue Disease Research Center. My research field is Behcet’s disease, vasculitis and palindromic rheumatism. I have 115 articles in English indexed in Scopus.

Dinesh Khanna

University of Michigan, United States

Dinesh Khanna, MD, MSc, is Professor of Medicine and Director, University of Michigan Scleroderma Program. He holds the Frederick G.L. Huetwell Professorship in Rheumatology. Dr. Khanna has published over 450 peer-reviewed articles and book chapters. He is the Principal Investigator on National Institutes of Health and industry-sponsored clinical studies. He is the coordinating PI on investigator-initiated and pharmacetucal sponsored clinical trials in scleroderma. His current research focus on developing, validating, and refining outcome measures in rheumatic diseases and designing controlled trials. He received the prestigious 2015 Henry Kunkel Young Investigator Award from the American College of Rheumatology.

Prof. Masataka Kuwana

Nippon Medical School, Japan

Dr. Masataka Kuwana is a professor of rheumatology and a director of scleroderma/myositis center of excellence at Nippon Medical School in Tokyo, Japan. Dr. Kuwana has published more than 430 peer-reviewed scientific articles and written more than 10 book chapters. He is listed as an editorial board member of 7 peer-reviewed journals, and serves as an Editor-in-Chief of Modern Rheumatology and the Journal of Scleroderma and Related Disorders. Dr. Kuwana is considered an internationally recognized leading expert in systemic sclerosis, myositis, pulmonary hypertension, interstitial lung disease, and autoimmunity.

Prof Mitsumasa Kishimoto

Kyorin university school of medicine, Japan

Mitsumasa Kishimoto is currently serves as an associate professor at Kyorin University School of Medicine.

After completing the first training in Japan, he completed an Internal Medicine Residency program at the University of Hawaii, and a Rheumatology Fellowship program at New York University. In 2006 he took the role of Program Director of the Department of Rheumatology at the Kameda Medical Center, then from 2009 to 2019, clinical program director in St Lukes International hospital before moving on to accept his current positions in 2019.

Dr Kishimoto was certified by the American Board of Internal Medicine and Rheumatology and received an ACR Distinguished Fellow Award in 2006.

He was a Steering committee member in the ‘APLAR guidelines for management of rheumatoid arthritis and is currently SIG member in Spondyloarthritis. He also serves as a Steering committee member in JCR guidelines for management of RA, PsA, and SpA, and Epidemiological survey of SAPHO syndrome in Japan.

He is a GRAPPA and ASAS member, and Japan’s Principal Investigators for the ‘ASAS-Comospa and perSpA’ studies.

Dr Kishimoto is an author of over 110 scientific publications including NEJM and Lancet articles.

Ms. Kwok Suet Kei

Hospital Authority, Hong Kong

Ms Kwok obtained Master of Nursing degree at the University of Hong Kong in 2004 and Graduate Certificate in Rheumatology Practice in the UK in 2009.  

She is now the advanced practice nurse-in-charge of Rheumatology and Clinical Immunology Centre of Grantham Hospital. She is also the Chairman of education committee and executive member of the Hong Kong Arthritis and Rheumatism Foundation.

She was the program development committee member of the Hong Kong rheumatology nursing curriculum and core working group member of the Asia-Pacific Initiative for Rheumatology Nurse Education since 2016.  

Ms Kwok was the author of randomized control trial on nurse-led consultation for patients with rheumatoid arthritis; co-author of published articles on SpA, Rheumatology Nurse education and development in Asia Pacific. She has ongoing research collaboration with EULAR champion countries on recommendations for patient education in inflammatory arthritis.

A/Prof Yohei Kirino

Yokohama City University, Japan

Graduated from Yokohama City University School of Medicine in 2001, and completed the doctoral program at the same university’s Graduate School of Medicine in 2006. After a fellowship in internal medicine and rheumatology, I joined the US NIH/NHGRI Dr. Kastner Lab as a visiting fellow. I am currently working at Yokohama City University Hospital as an adult rheumatologist. My interests include adult autoinflammatory diseases such as Behcet’s disease, VEXAS syndrome, and adult Still’s disease.

Dr. Laura Lewandowski

Head, Lupus Genomics and Global Disparities Unit, NIAMS, NIH, United States

Dr. Laura Lewandowski completed pediatric residency training at the University of Massachusetts Medical Center and went on to serve as a chief resident in pediatrics. During her chief resident year, she developed a specialty track for pediatric residents in Global Health, including curriculum design and coordination of international rotations. She completed a combined four-year pediatric rheumatology/ global health fellowship at Duke University Medical Center, during which she characterized a pediatric lupus patient cohort in South Africa. She holds a Masters in Global Health from Duke University. During her fellowship, she collaborated with Dr. Chris Scott to establish a registry of pediatric lupus patients that continues to grow and is now the largest cohort in sub-Saharan Africa. She was awarded a Fogarty Global Health Fellowship and a Lupus Foundation Early Career award for her work with pediatric lupus patients in South Africa.

In 2015, she joined the NIAMS under Dr. Mariana Kaplan as a Lawrence Shulman Scholar in Translational Medicine. She currently holds the position of Assistant Clinical Investigator and Head of the Lupus Genomics and Global Health Disparities Unit at NIAMS, NIH. Her current research interests include clinical and translational research in pediatric systemic lupus erythematosus (SLE), with a focus on genetic drivers of severe disease and inflammation in varied cohorts around the world.

Dr. Lewandowski has held several leadership positions including serving as co-chair Childhood Arthritis and Rheumatic Diseases Research Alliance (CARRA) Lupus Nephritis workgroup, co-chair of the CARRA Lupus Genetics Workgroup, chair of the CARRA Translation Research and Technology Committee Data Management, and chair CARRA Annual Meeting Planning Committee. She is a member of Early Career Investigator Committee within the American College of Rheumatology; whose aim is to develop the next generation of researchers in the rheumatology field. In addition, she has mentored students and trainees in North America and South Africa in rheumatology research. She is a USA representative on the Paediatric Musculoskeletal Task Force. She has published many articles on lupus in Africa and the challenges to rheumatology clinical care, education and practice in less resourced countries. She has lectured nationally and internationally on the genetics of pediatric lupus in global populations and global rheumatology clinical care and research.

Dr. Philip Li

The University of Hong Kong, Hong Kong

Dr Philip Li is a Specialist in Immunology & Allergy and Clinical Assistant Professor under the Department of Medicine at the University of Hong Kong.

Dr Li has led the development of the in-patient drug allergy and immunology service as well as establishing the Immunology Clinics at Queen Mary and Grantham Hospitals. Dr Li is also a council member of the Hong Kong Institute of Allergy, executive committee member of the Hong Kong Allergy Association, and the Asia Pacific Association of Allergy Asthma and Clinical Immunology’s Drug Allergy Committee.

Dr Li has special interests in anaphylaxis, drug hypersensitivity and immunodeficiency. He conducted the region’s foremost drug allergy studies and now leads Hong Kong’s territory-wide drug allergy de-labelling initiative. He has published over 70 peer-reviewed articles in the fields of allergy, immunology and autoimmunity; and serves on the Editorial Boards of Frontiers in Allergy and Journal of Clinical Rheumatology and Immunology.

Prof. Worawit Louthrenoo

Thailand

Professor Worawit Louthrenoo is a rheumatologist at the Faculty of Medicine, Chiang Mai University, Thailand. He completed his Rheumatology Fellowships training at Mahidol University, Bangkok, Thailand in 1986, and at the University of Pennsylvania School of Medicine, USA, in 1991. His main interests are crystal-associated arthropathy, systemic lupus erythematosus, systemic sclerosis, rheumatoid arthritis and infectious arthritis. Professor Louthrenoo serves in several professional associations executive committee, including APLAR. He has had over 80 book chapters and 150 journal articles published. He receives frequent invitations to speak at national and international rheumatology events. He has received many awards, including The Best Internist Award in 2010, Best Researcher Award from Chiang Mai University in 2011, Best Teacher Award in 2013, and recently The Dushdi Mala Medal from His Majesty the King Rama X in 2021.

Dr Kuo-Lung Lai

Division Of Allergy, Immunology And Rheumatology, Department Of Internal Medicine, Taichung Veterans General Hospital, Taiwan

Dr. Kuo-Lung Lai is a rheumatologist in Taichung Veterans General Hospital (TCVGH). He got M.D. degree at National Yang-Ming University in 2001, and currently is a Ph.D. candidate in Graduate Institute of Biomedical Electronics and Bioinformatics in National Taiwan University. He had been a member of the Board of Directors of SUMROC during 2010-2012. He has been the major supervisor of musculoskeletal ultrasound (MSUS) program in TCVGH since 2013 and carried out several MSUS studies of rheumatic diseases. His current research fields include ultrasonography in rheumatoid arthritis and psoriatic arthritis, ultrafast Doppler and medical image processing. He is a reviewer of the following academic journals: Journal of Medical Ultrasound, Ultrasound in Medicine and Biology, Formosan Journal of Rheumatology, and International Journal of Rheumatic Diseases.

Prof Chak-Sing Lau

The University of Hong Kong, Hong Kong

Professor Chak-Sing Lau is currently Chairperson of the Department of Medicine and Chairman of the Board of the Li Ka Shing Faculty of Medicine, the University of Hong Kong. He is also Chief of Service of the Queen Mary Hospital Department of Medicine.

Professor Lau graduated MBChB from the University of Dundee in 1985. In 1992, he joined the University of Hong Kong (HKU) as Lecturer in Medicine and successfully rose through the ranks to Senior Lecturer in 1997 and Professor in 2000. He returned to his Alma Mata in 2007 to become the first Chair of Rheumatology of the College of Medicine, Dentistry and Nursing Studies. In 2010, however, he began his second tenure at HKU as Chair Professor and later (2014) Daniel CK Yu Professor in Rheumatology and Clinical Immunology.

Within HKU Medicine, Professor Lau was Assistant Dean in Information Technology and Planning (2001 – 2004), Assistant Dean in Education and Student Affairs (2005 – 2007), Director of the Bau Institute of Medical and Health Sciences Education (2010 – 2018) and Associate Dean for Teaching & Learning (2013 – 2018). In 2016, he co-led the reform of the MBBS Curriculum incorporating a one-year enrichment experience for all medical students .

Professor Lau has been a major player in rheumatology in Hong Kong and beyond. Locally, he was President of the Hong Kong Society of Rheumatology (1997 – 2001) and Chairman of the Hong Kong College of Physicians Subspecialty Board in Rheumatology, Immunology & Allergy (2001 – 2007). In 2001, he founded the Hong Kong Arthritis & Rheumatism Foundation, the first and only local charity organisation that raises funds to support the psychosocial and therapeutic needs of patients with rheumatic diseases. Regionally, Professor Lau co-founded the Asian Congress on Autoimmunity, Huaxia Congress on the Management of Rheumatic Diseases and Ten Topics in Rheumatology in Asia. Notably, he was President of the Asia Pacific League of Rheumatology Associations (APLAR) between 2006 and 2008. In addition, Professor Lau led the development of the Region’s first treatment recommendations for rheumatoid arthritis and axial spondyloarthritis. In 2011, he co-founded the multi-national, multi-centre Asia Pacific Lupus Collaboration . Beyond the Asia Pacific region, Professor Lau is a member of the Outcomes in Rheumatology, European League Against Rheumatism (EULAR) Scientific Committee and EULAR Task Force on Rheumatoid Arthritis Treatment Recommendations.

Between 2016 and 2020, Professor Lau was President of the Hong Kong Academy of Medicine, having served as Vice-President (Education and Examinations) in the previous 5 years. Professor Lau sits on numerous strategic committees and working groups of the Food and Health Bureau, Hospital Authority, Department of Health and the Medical Council of Hong Kong. In December 2020, he was appointed by the Hong Kong SAR Government as Convenor of the Advisory Panel on COVID-19 Vaccines.

Dr Vince Lau

Gleneagles Hospital, Hong Kong

Dr Vince Lau is currently the Consultant at the Department of Radiology, Gleneagles Hospital, Hong Kong. He is also Honorary Clinical Associate Professor at University of Hong Kong and Honorary Consultant at Queen Mary Hospital.

His academic interests are Interventional Radiology and Musculoskeletal Imaging & Intervention.

Dr. Ka Wing Gavin Lee

Hong Kong Sanatorium & Hospital, Hong Kong

Dr. Lee graduated in The University of Hong Kong in 1990. In 1998, he established rheumatology service in Pamela Youde Nethersole Eastern Hospital.

In 2004, his unit was the first to introduce rheumatology MSK ultrasound in Hong Kong. Dr Lee actively promoted MSK USG locally and internationally; he had organized many ultrasound training workshops in Hong Kong and China. Moreover, he was invited as trainer in regional ultrasound training courses and he was an accredited ultrasound trainer under EULAR.

Dr Lee currently is the Director of the Rheumatology Centre of Hong Kong Sanatorium & Hospital. He is also the Honorary Associate Professor of both the University of Hong Kong and the Chinese University of Hong Kong.

Dr Lee has been elected as the Chairman of the Hong Kong Arthritis & Rheumatism Foundation, a charitable foundation to educate the public on rheumatic diseases and to serve patients suffering from various rheumatic diseases.

Dr. Victor Lee

CUHK Medical Centre, Hong Kong

Dr. Victor Lee is a consultant radiologist in CUHK Medical Centre, with subspecialty interests in interventional and musculoskeletal radiology.

After graduating from the University of Hong Kong, Dr. Lee received radiology training in Queen Mary Hospital and obtained Fellowship of the Hong Kong College of Radiologists in 2019. He has published more than 30 scientific articles in various local and international peer-reviewed journals including Radiology and Skeletal Radiology.

He is a member of MRI Special Interest Group of the Hong Kong Society of Rheumatology.

A/Prof. Katy Leung

Singapore General Hospital, Singapore

A/Prof. Ying Ying LEUNG is Associate Professor at Duke-NUS Medical School, and Senior Consultant of the department of Rheumatology & Immunology of Singapore General Hospital (SGH). She is currently the head of research in the department of Rheumatology and Immunology. Her research interests are in psoriatic arthritis and osteoarthritis, focusing in evaluation and development of measurement instrument and biomarkers.

A/Prof. Leung has been the Asian chair of the GRAPPA-OMERACT Outcome Measure working group, and serves in the education committee in the Group For Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She led the peripheral arthritis domain working group in the GRAPPA recommendation update 2021.

Prof. Vidya Limaye

Royal Adelaide Hospital, Australia

Vidya Limaye is a staff specialist Rheumatologist in the Department of Rheumatology at the Royal Adelaide Hospital. After completing her rheumatology training she undertook a PhD in the Vascular Biology Laboratory at the Hanson Institute studying the role of sphingosine kinase in inflammation and angiogenesis. She has since established the South Australian Myositis Database; this is a large repository of over 900 patients with myositis which has enabled the study of clinical, epidemiological and immunogenetic aspects of inflammatory myopathies. She has a particular interest in myositis-specific autoantibodies and in the increasingly recognised subgroup of patients with necrotising myopathy.

Prof. Liwei Lu

The University of Hong Kong, Hong Kong

Liwei Lu is currently a Professor of Immunology at University of Hong Kong.

Professor Lu’s research has focused on studying immune dysregulations in autoimmune diseases. He has published over 150 peer-reviewed papers in leading immunology and rheumatology journals. He has served as Chairman of Hong Kong Society for Immunology and a Councilor, Federation of Immunological Societies of Asia-Oceania. His academic achievements have been recognized with numerous awards including David Rae Memorial Award, Leukemia Research Fund of Canada in 2000, Croucher Senior Research Fellowship Award in 2012, HKU Outstanding Researcher Award in 2013, China Medical Science Award in 2018 and World’s Top 1% Scientists (Clarivate/Web of Science, 2019-2021).

Prof. Ingrid Lundberg

Karolinska Institutet, Sweden

Doctor Ingrid Lundberg is professor in rheumatology at Karolinska Institutet combined with a position as senior consultant at Karolinska University hospital.

Dr I. Lundberg established a myositis clinic with a dedicated multidisciplinary team in 1993 at Karolinska University Hospital. This clinic has formed the basis of a translational research project with the aim to achieve improved understanding of molecular mechanisms that lead to muscle weakness and immune reactivity in patients with myositis.

Through her research her team has demonstrated that physical exercise, in contrast to the recommendations at that time, leads to increased muscle strength and improved performance. Dr Lundberg and her team have detected a new myositis specific autoantibody, anti-FHL1 autoantibodies that are associated with a severe phenotype of myositis, and they have identified antigen specific T cells targeting histidyl-tRNA synthetase.
Dr Lundberg and her team have undertaken therapeutic mechanistic studies using anti-TNF, and anti-IL-1 treatment, high dose IVIg and abatacept as well as physical exercise with studies on clinical outcome and effect on molecular expression in muscles and peripheral blood.

Dr Lundberg is member of a team that founded and developed an international, multidisciplinary, web-based myositis register, www.euromyositis.eu which now has more than 6 000 patients from 23 centers world-wide enrolled. She is the PI of the International Myositis Classification Criteria Project (IMCCP) published in 2017 “European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups” (Lundberg,IE et al. Ann Rheum Dis. 76:1955-1964 2017; Arthritis Rheumatol.69:2271-2282, 2017.)

Assoc. Prof. Dr. PhD Peter Mandl

Division Of Rheumatology, Medical University Of Vienna, Austria

Prof. Mandl is a chief consultant and associate professor at the Division of Rheumatology, Medical University of Vienna, Austria, a EULAR Centre of Excellence and member of the EULAR Network of Imaging Research Centers. After graduating with honors from Semmelweis University, Budapest he completed my doctorate in functional neuroscience with honors at the Nathan Kline Institute in Orangeburg, New York and at Semmelweis University, Budapest.

His research interests include the use of imaging for diagnosing, monitoring and predicting rheumatic and musculoskeletal diseases, in particular the utility of ultrasound for the monitoring of inflammation and structural changes in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. He has convened and am currently convening several EULAR and OMERACT task forces which focus on various aspects of imaging. He has published over 90 peer-reviewed publications within the field of rheumatology and musculoskeletal imaging with and H-index of 28, and published a textbook on the use of musculoskeletal ultrasound for the hand.

Prof. Ashish Jacob Matthew

Christian Medical College, Vellore, India

Ashish J Mathew is a professor of rheumatology at the Christian Medical College, Vellore, India and an adjunct research associate at the Copenhagen Center for Arthritis Research (COPECARE), Copenhagen University Hospital-Rigshospitalet, Glostrup, Denmark. He completed his basic medical education and rheumatology training in India, followed by a PhD in ‘MRI and clinical aspects of enthesitis in spondyloarthritis, including psoriatic arthritis’ from the University of Copenhagen, Denmark and an advanced clinical research fellowship in rheumatology focussing on psoriatic arthritis from the University of Toronto. His research is focussed around psoriatic arthritis and spondyloarthritis. He has 65 publications in peer reviewed journals and has authored 6 textbook chapters. He is an active member of the GRAPPA , ASAS and OMERACT MR imaging and PsA groups.

Prof. Iain McInnes

United Kingdom

Iain McInnes is Vice Principal and Head of College of Medical Veterinary and Life Sciences, and Versus Arthritis Professor of Rheumatology in the University of Glasgow, Glasgow, United Kingdom. He is Director of the Versus Arthritis Centre of Excellence for Inflammatory Arthritis, lead from Glasgow that includes Universities of Oxford, Newcastle and Birmingham. He is immediate past chairman of the Foreum (Foundation for European Rheumatology Research) Scientific Committee, leads the European Roadmap programme that is defining the research agenda for European rheumatology for the next decade and is currently President of the European League Against Rheumatism (EULAR), the leading trans-national society for rheumatology across Europe.

Under these auspices he is creating the first pan-European Rheumatology Research Centre planning to launch in 2021. His work is mainly focused upon the understanding of the pathogenesis of immune mediated inflammatory diseases and encompasses basic discovery immunology through phase 1 and proof of concept experimental medicine clinical trials to leadership of pivotal phase 3 trials in the area of immune biology. His laboratory group performed original discovery work leading to the therapeutic targeting of a several inflammatory cytokines. More recently he has focused on the biology of myeloid cells in the pathogenesis of a number of immune diseases. He has published >400 peer-reviewed original and review articles with an h-index of >100. He is a Fellow of the Royal Society of Edinburgh and Fellow of the Academy of Medical Sciences. He was made CBE in 2019 by HM Queen Elizabeth II.

A/Prof. Takako Miyamae

Tokyo Women’s Medical University, Japan
Dr. Takako Miyamae is an Associate Professor in Pediatric Rheumatology, Institute of Rheumatology, Tokyo Women’s Medical University in Tokyo, Japan. She is the president of the Pediatric Rheumatology Association of Japan.

Prof. Ingrid Moller

Instituto Poal De Reumatologia Barcelona, University Of Barcelona International University Of Catalunya, Spain
  • Director and consultant in Rheumatology and musculoskeletal sonography at the Institut Poal de Reumatología, Barcelona 1997
  • Assistant professor of anatomy, University of Barcelona from 2011
  • Assistant professor of Medical Image, International University of Catalunya
  • Organizer of the SONOANATOMY Workshops under the scientific endorsement of EULAR (2007-2020 ongoing)
  • Faculty and co-director of the Sonoanatomy master program, Rheumatologic pathologies master program and the diploma of Experts in musculoskeletal ultrasound from the University of Barcelona
  • Faculty of The Ultrasound School of the Spanish Society of Rheumatology from 2002
  • Faculty of the EULAR courses of Ultrasound from 2007
  • Founder of the EULAR WORKING GROUP ANATOMY FOR THE IMAGE
  • Chair of EULAR working task:
    • Anatomy for The Image
    • Synovial Biopsy
  • Speaker at the ACR and EULAR meeting from 2007.
  • Co-author of book´s chapters in EULAR text book of Rheumatic diseases, Oxford textbook of Rheumatology, Manual SER de enfermedades reumaticas,
  • Co-Author of “photographic atlas of musculoskeletal ultrasound” (2012)
  • Author of numerous articles related to the specialty mainly referred to musculoskeletal ultrasound : https://scholar.google.es/citations?user=VaD7Bm8AAAAJ&hl=es 

Prof. Sandra Navarra

University Of Santo Tomas, Philippines

Prof. Sandra Navarra is head of Rheumatology at University of Santo Tomas Hospital in Manila, Philippines. She is co-convenor of SLE special interest group at Asia Pacific League of Associations (APLAR), steering committee member of Lupus Academy, executive board member of Asia-Pacific Lupus Collaboration, and founding member of Asia Lupus Nephritis Network. In addition to clinical practice, teaching, and numerous health advocacies, Prof. Navarra is an experienced clinical trials investigator and has published widely in the field of lupus, spondyloarthropathy and other rheumatic diseases. She is a well-known lecturer in a broad range of topics in rheumatology and recipient of several university, national and regional awards including the Philippine College of Physicians Most Distinguished Physician award and the APLAR Master award.

Prof. Fai Ng

Newcastle University, United Kingdom

Professor Ng, Professor of Rheumatology at Newcastle University and Honorary Consultant Rheumatologist at Freeman Hospital, is an international leader in Sjögren’s syndrome and fatigue research. He is the Director of the NIHR Newcastle Clinical Research Facility.

Ng established the UK primary Sjögren’s syndrome registry (UKPSSR) with over 1000 patients. The UKPSSR has to date supported many national and international research projects peer-reviewed publications, and leveraged an additional £50M in grant awards.

Professor Ng leads several large international and national research consortia including a €42 million EU IMI consortium – IDEA-FAST (www.idea-fast.eu).

He completed his medical degrees at Cambridge University and a doctoral degree at Imperial College London. He is a Michael Mason Prize winner of the British Society for Rheumatology.

Dr. Rachel Nelligan

The University Of Melbourne, Australia

Rachel Nelligan is a registered clinical physiotherapist and research fellow in the Department of Physiotherapy at the University of Melbourne. As an early career researcher Rachel has been involved in the design, development and execution of >7 randomised controlled trials researching osteoarthritis, pelvic health and exercise with a particular focus on digital-health and behaviour change. Rachel has >21 peer-reviewed publications and recently received the 2021 Australian Rheumatology Association’s New Investigator Award and the 2021 Australian Clinical Trials Alliance’s Emerging Leader Award for her work in digitally-delivered interventions for people with knee osteoarthritis. She was also a 2021 finalist for the Victorian Government’s Premier’s Awards for Health and Medical Research.

Prof. Alexis Ogdie

University of Pennsylvania, United States

Dr. Ogdie is Associate Professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania. She is an expert in the care of patients with PsA, Director of the Penn Psoriatic Arthritis and Spondyloarthritis Program and Deputy Director of the Penn Center for Clinical Epidemiology and Biostatistics. Her research program is focused psoriatic arthritis (PsA), an inflammatory arthritis that affects up to 30% of patients with psoriasis. The mission of her research program is to improve outcomes in PsA by accelerating diagnosis, increasing the focus on meaningful, patient-centered outcomes, and developing and advancing methods for precision medicine.

A/Prof. Kenji Oku

Department of Rheumatology and infectious Diseases, Kitasato University, Japan

Kenji Oku is an associate professor of the Department of Rheumatology and Infection Diseases at the Kitasato University, Japan. His interests have focused on both basic science and clinical research in SLE and the antiphospholipid syndrome.
Most recently, as the member of the standing committee of the APLAR, he and his colleagues published the Consensus Statements on the Management of SLE. Additionally, as fellow of Japan College of Rheumatology (JCR), he holds various senior level positions in the JCR, including the executive director of the standing committee of the Japanese clinical guidelines of SLE and the senior member of the task force against COVID-19.

Dr. Kade Paterson

Centre For Health, Exercise & Sports Medicine, He Unversity Of Melbourne, Australia

Dr Kade Paterson is a NHMRC Emerging Leadership Fellow and a Dame Kate Campbell Senior Research Fellow with the Centre for Health, Exercise and Sports Medicine at the University of Melbourne. He is also a Certified Sports Podiatrist with Lakeside Sports Medicine Centre. Kade’s research expertise is in conducting large clinical trials testing non-drug, non-surgical interventions for musculoskeletal conditions, and for osteoarthritis in particular. He has published more than 65 peer-reviewed articles in international journals, is a co-author of a biomechanics textbook and has presented at numerous national and international conferences. Kade’s clinical career has spanned 15 years, where he works widely with professional and recreational athletes and clubs from around Australia, including his current role with Melbourne United in the National Basketball League. He is the President of Sports and Exercise Podiatry Australia, is on the Victorian Council for Sports Medicine Australia, and is a Fellow of the Australian Sports Medicine Federation.

Dr. Jung Yoon Pyo

Yonsei University College Of Medicine, South Korea
Professional Appointments

Since 2020 Clinical Assistant Professor, Division of Rheumatology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2018-2020 Assistant Professor, Division of Rheumatology, Department of Internal Medicine, Wonju Severance Hospital, Yonsei Wonju University College of Medicine, Wonju, Korea
2017-2018 Clinical Assistant Professor, Division of Rheumatology, Department of Internal Medicine, Wonju Severance Hospital, Yonsei Wonju University College of Medicine, Wonju, Korea
2016-2017 Clinical Research Assistant Professor, Division of Rheumatology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
2015-2016 Clinical Fellow, Division of Rheumatology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea

Education

2002-2008 M.D. Yonsei University College of Medicine, Seoul, Korea

Prof. Chaim Putterman

Bar Ilan Universtiy/Albert Einstein College Of Medicine, United States

Dr. Putterman serves as Associate Dean for Research in the Azrieli School of Medicine of Bar-Ilan University, and Director of the Research Institute in the Galilee Medical Center. In addition, Dr. Putterman is Professor of Medicine and Microbiology & Immunology at the Albert Einstein College of Medicine and Montefiore Medical Center (Bronx, New York).

Dr. Putterman’s major research interests are in the field of immunology and autoimmune diseases, and specifically the identification and characterization of novel mechanisms, biomarkers, and treatment approaches to immune mediated nephritis, neuropsychiatric lupus, and systemic lupus erythematosus. Dr. Putterman’s laboratory has received funding from the National Institute of Health, Alliance for Lupus Research, Lupus Research Institute, Arthritis Foundation, Boehringer Ingelheim, and Biogen Idec, and he has published more than 200 articles and book chapters in the medical and scientific literature. He was elected to the American Society of Clinical Investigation, and is a member of the American College of Rheumatology and the American Association of Immunologists. Dr. Putterman has served on multiple NIH and international study sections, and is currently a member of several editorial boards.

Dr Anthony Michael Sammel

Prince Of Wales Hospital, Australia

Dr Anthony Sammel is a rheumatologist in Sydney, Australia with a subspecialty interest in vasculitis. He works at Prince of Wales Hospital and is a conjoint senior lecturer at the University of New South Wales. He completed a PhD in advanced PET/CT imaging and biomarkers in giant cell arteritis and is a director of the Australian and New Zealand Vasculitis Society (ANZVASC). Dr Sammel’s research focuses on imaging in large vessel vasculitis.

Prof. Chris Scott

University Of Cape Town, South Africa

Dr. Scott is Professor and head of Paediatric Rheumatology at Red Cross War Memorial Children’s Hospital and the University of Cape Town. He is currently interim director of the Clinical Research Center at UCT. His research and educational focus is on the care of patients with rare and rheumatic diseases in Africa and other less resourced communities. Prof Scott has a special interest in access to care, Paediatric Vasculitis, SLE, Juvenile Idiopathic Arthritis and Fibrodysplasia Ossificans Progressiva. He is the PReS Chairperson of the Global Task Force for Musculoskeletal Health Task Force and chair of the International Clinical Council for FOP. He also serves on the Steering committee of the Paediatric Society of the African League of Associations for Rheumatology.

Prof. Kichul Shin

Seoul Metropolitan Government-seoul National University Boramae Medical Center, South Korea

Kichul Shin is a Rheumatologist, and Professor of Seoul National University (SNU), Seoul, Korea. He completed his fellowship at SNU hospital and Brigham and Women’s Hospital in Boston, USA. He is the Chair of the Clinical & Basic Research Committee of the Korean College of Rheumatology, and has been running the biologic register, KOBIO as Director since 2013. He is also a member of the APLAR Executive Committee, and APLAR Center of Excellence Committee.

Prof. Lai-Shan Tam

The Chinese University Of Hong Kong, Hong Kong

Lai-Shan Tam, MD, is Division Head and a Professor at The Chinese University of Hong Kong. She was APLAR Vice President (2014-2016), chairperson of the APLAR International Affair Committee (2012-2021), CoE committee and the APLAR Academy co-ordinator (since 2021). Professor Tam was a member of the ACR International Task Force Subcommittee, EULAR Programme Committee (2016-2019), and EULAR honorary member (since 2019). She serves as the Associate Editor of International Journal of Rheumatic Disease and Arthritis Research and Therapy, and she is also the international advisory board member of the Lancet Rheumatology. She is the first author or co-author of over 240 articles published in major rheumatology journals. Her research interests include premature atherosclerosis and bone loss in patients with rheumatic diseases.

Prof. Yoshiya Tanaka

University of Occupational and Environmental Health, Japan

Yoshiya Tanaka, MD, PhD is Professor and Chairman of the First Department of Internal Medicine, School of Medicine (2000-present) and Dean of Graduate School of Medical Science, University of Occupational and Environmental Health, Japan. He reviewed 820 publications (impact factor 4850, h-index 88) in English. His scientific focus lies on pathological mechanisms and development of novel treatments in systemic autoimmune diseases. He is the president of JACI, chair of intenational committee of APLAR, chair of international committee of JCR and board member of many societies. He is also an editor-in-chief of MRCR, an associate editor of Rheumatology, Cytokine, AR&T, IJRD and many, an editorial board member of ARD, RMD Open, MR, etc. He has received numerous awards from JSBMR, JCR and EULAR.

Prof. Annette Van der van Mil

Leiden University Medical Center, Netherlands

Annette van der Helm-van Mil obtained her medical degree in 1998 (cum laude), was ratified as internist in 2005 and as rheumatologist in 2006 and obtained her Ph.D. degree in 2006 (cum laude). She was head of the rheumatology outpatient clinic in Leiden from 2007 till 2016.

Since 2015 she is appointed as professor at the departments of rheumatology in the Leiden University Medical Center, Leiden and in the Erasmus Medical Center, Rotterdam, the Netherlands. Her research is aimed at understanding the processes underlying disease progression in the earliest phases of rheumatoid arthritis and predicting the disease course of patients presenting with arthralgia and early arthritis. She supervises the Leiden Early Arthritis cohort, the multicenter Clinically Suspect Arthralgia cohort that runs in Leiden and the Rotterdam area, and the TREAT EARLIER trial.

She has authored >300 articles and has received several grants and prizes, among which grants from the Dutch Scientific Organization, the Dutch Arthritis Foundation and an ERC Starting Grant. Her research line in the two university hospitals into the earliest phases of rheumatoid arthritis has been recognized by the Dutch Arthritis Society as a Research Center of Excellence.

Prof. Chrong-Reen Wang

National Cheng Kung University Hospital And Medical College, Taiwan

Chrong-Reen Wang is a rheumatologist at National Cheng Kung University Hospital and Medical College. He holds the position of full Professor at Internal Medicine Department since 2010. His research interest is in antiphospholipid syndrome, inflammatory arthritis, systemic lupus erythematosus and vasculitis syndrome.

He received MD from National Taiwan University in 1987, obtained Lecturer at the Internal Medicine Department of National Taiwan University Medical College in 1993, received PhD from the University of Tokyo (Basic Medical Sciences III) in 1999, and joined American College of Rheumatology as a fellow in 2008.

Dr. Priscilla Wong

The Chinese University of Hong Kong, Hong Kong

Dr Priscilla Wong is a specialist in Rheumatology and an Honorary Clinical Associate Professor of the Department of Medicine and Therapeutics at the Chinese University of Hong Kong. She is a EULAR accredited ultrasound trainer and a core member of the Ultrasound Special Interest Group of the Hong Kong Society of Rheumatology. She has been an instructor of various basic ultrasound workshops in Hong Kong and mainland China. Currently, she is also the Convenor of Asia Pacific League of Associations for Rheumatology Young Rheumatologists, and the Council Member of the Hong Kong Society of Rheumatology.

Prof. Tian Xinping

Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College, China

Dr. Tian is now the Professor of medicine of Peking Union Medical College Hospital. She has been a rheumatologist for more 30 years. Her research interest in vasculitis including large vessel vasculitis and small vasculitis. She also interested in the management of high risk pregnancies associated with rheumatic diseases.

Prof. Guochun Wang

China-japan Friendship Hospital, China

Dr Guochun Wang, MD,PhD

Dr. Wang is a professor of medicine, the Director of the Rheumatology Department and the Key Laboratory of Myositis at China-Japan Friendship Hospital/Peking University Teaching Hospital. He has extensive clinical and research experience of working with idiopathic inflammatory myopathies (IIMs) patients. He is the recipient of grants from the National Natural Science Foundation of China and many other research institutions. Dr. Wang has been in charge of a wide range of research programs in IIMs including observational studies, immunological studies, genetic studies, serological studies, muscle pathological and imaging studies. Moreover, Dr. Wang is the author or corresponding author of more than 100 pubmed-indexed articles which focused on myositis. Dr. Wang has been active in international myositis and rheumatology professional societies.

MD Julie Yu

Philippine Rheumatology Association, Philippines

Chair – Section of Rheumatology, University of Santo Tomas Faculty of Medicine and Surgery
Chair – Osteoporosis Special Interest Group, Philippine Rheumatology Association
Chair – Department of Medical Education and Research, Chinese General Hospital and Medical Center
Immediate Past President – Philippine Rheumatology Association and Osteoporosis Society of the Philippines Foundation, Inc.

Prof. Raymond Yung

University of Michigan, United States

Professor Raymond Yung is the Jeffrey B. Halter Collegiate Professor of Geriatric Medicine at the University of Michigan in the United States. His clinical and research interest is in Geriatric Rheumatology. He is currently Chief of the Division of Geriatric and Palliative Medicine, Director of the Michigan Geriatrics Center and Institute of Gerontology. He also served as Chief of the Division of Rheumatology in 2018-2020 at the University of Michigan.

Prof. Kazuhiko Yamamoto

Riken Center for Integrative Medical Sciences, Japan

Kazuhiko Yamamoto graduated from the University of Tokyo School of Medicine in 1977. After finishing his training and residency in internal medicine and rheumatology, he conducted basic research in Tokyo and in Heidelberg. In 1997, he was promoted to be the professor and chairman of Department of Allergy and Rheumatology, the University of Tokyo Graduate School of Medicine. In 2017, he reached the mandatory retirement age of the University of Tokyo and moved to RIKEN Center for Integrative Medical Sciences. In 2020, he become the director. He is also an emeritus professor of the University of Tokyo. Dr. Yamamoto’s research interests include genetic and functional genetic analyses of autoimmune diseases.

Prof. Zhuo-Li Zhang

Peking University First Hospital, China